1. Dysfunctional Homozygous VRK1-D263G Variant Impairs the Assembly of Cajal Bodies and DNA Damage Response in Hereditary Spastic Paraplegia
- Author
-
Boris Keren, Pedro A. Lazo, Paulino Gómez-Puertas, Iñigo Marcos-Alcalde, Fanny Mochel, Patricia Morejón-García, Ministerio de Educación (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Junta de Castilla y León, European Commission, Gestionnaire, HAL Sorbonne Université 5, Universidad de Salamanca, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Hereditary spastic paraplegia ,DNA damage ,All Neuromuscular Disease ,Article ,03 medical and health sciences ,0302 clinical medicine ,All Genetics ,medicine ,[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Transcription factor ,Genetics (clinical) ,030304 developmental biology ,Genetics ,0303 health sciences ,biology ,Kinase ,Developmental disorders ,Spastic paraplegia ,medicine.disease ,Activating transcription factor 2 ,nervous system diseases ,3. Good health ,Histone ,Cajal body ,biology.protein ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Coilin ,Neurology (clinical) ,030217 neurology & neurosurgery - Abstract
[Background and Objectives]: To conduct a genetic and molecular functional study of a family with members affected of hereditary spastic paraplegia (HSP) of unknown origin and carrying a novel pathogenic vaccinia-related kinase 1 (VRK1) variant., [Methods]: Whole-exome sequencing was performed in 2 patients, and their parents diagnosed with HSP. The novel VRK1 variant was detected by whole-exome sequencing, molecularly modeled and biochemically characterized in kinase assays. Functionally, we studied the role of this VRK1 variant in DNA damage response and its effect on the assembly of Cajal bodies (CBs)., [Results]: We have identified a very rare homozygous variant VRK1-D263G with a neurologic phenotype associated with HSP and moderate intellectual disability. The molecular modeling of this VRK1 variant protein predicted an alteration in the folding of a loop that interferes with the access to the kinase catalytic site. The VRK1-D263G variant is kinase inactive and does not phosphorylate histones H2AX and H3, transcription factors activating transcription factor 2 and p53, coilin needed for assembly of CBs, and p53 binding protein 1, a DNA repair protein. Functionally, this VRK1 variant protein impairs CB formation and the DNA damage response., [Discussion]: This report expands the neurologic spectrum of neuromotor syndromes associated with a new and rare VRK1 variant, representing a novel pathogenic participant in complicated HSP and demonstrates that CBs and the DNA damage response are impaired in these patients., P. M-G. was supported by Ministerio de Educación-FPU predoctoral fellowship (FPU16/01883). This work was funded by grants from Agencia Estatal de Investigaci´on/ Ministerio de Ciencia e Innovaci´on (PID2019-105610RBI00) and Consejería de Educación-Junta de Castilla y León (CSI264P20) to P.A.L. Agencia Estatal de Investigaci´onMinisterio de Ciencia, Innovaci´on y Universidades (RTC2017-6494-1 and RTI2018-094434-B-I00) and European Commission project “CONNECT-JPIAMR Virtual Research Institute” to P.G-P. The Instituto de Biolog´ıa Molecular y Celular del Cancer is funded by a grant from Junta de Castilla y León-FEDER (CLC-2017-01).
- Published
- 2021
- Full Text
- View/download PDF